Chester County News and Community Website
NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced a 1-for-50 reverse split of its Class A common stock, set to take effect at 5:00 pm Eastern time …
Helius Medical Announces 1-for-50 Reverse Stock Split Read More
NEWTOWN, PA — Gentell has announced the acquisition of Casex, a well-established Latin American manufacturer of ostomy and wound care products. The acquisition, finalized on June 5, 2025, marks a …
Gentell Expands Global Presence with Acquisition of Casex Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) has revealed new preclinical findings and a clinical update on APR-1051, an innovative oral WEE1 inhibitor being studied for the treatment of …
Aprea Therapeutics Announces Promising Data on APR-1051 for HPV-Positive Cancers Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) announced it has reacquired full global rights to its lead RNAi compound, imdusiran, following the conclusion of its strategic partnership with Qilu …
Arbutus Biopharma Reacquires China Rights to Imdusiran, Forms Scientific Advisory Board Read More
NEWTOWN, PA — EPAM Systems, Inc. (NYSE: EPAM) has announced the launch of DIAL 3.0, the latest version of its open-source Generative AI (GenAI) platform. More than just a platform …
EPAM Systems Unveils DIAL 3.0, Advancing Enterprise AI with Open-Source Innovation Read More
YARDLEY, PA & LONDON — Herspiegel has announced its acquisition of Decisive Consulting, a firm renowned for its bold and innovative approach to global market access. The move marks a …
Herspiegel Acquires Decisive Consulting to Expand Global Market Access Capabilities Read More
NEW HOPE, PA — Poxono Capital, a Pennsylvania-based registered investment advisor, has appointed Wilder Harvard as its new President. Harvard steps into the role with more than 20 years of …
Wilder Harvard Joins Poxono Capital as President Read More
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has presented key clinical insights into its atrioventricular interval modulation (AVIM) therapy for high-risk hypertension during the Congenital, Structural, and …
Orchestra BioMed Highlights AVIM Therapy’s Potential at CSI 2025 Meeting Read More
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the publication of findings from its Phase 2 SEISMiC B study on istaroxime in the Journal of Heart and Lung …
Windtree Therapeutics Announces Promising Phase 2 Study Results for Istaroxime Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced that CignaHealth has authorized claims for payment of the company’s Portable Neuromodulation Stimulator (PoNS) Device. The authorization marks a …
Helius Medical Technologies Secures Fifth Major Payer Authorization for PoNS Device Read More